KR20010043216A - 1-(6-클로로나프트-2-일설포닐)-4-[4-(4-피리딜)벤조일]피페라진의 입도가 감소된 제형 - Google Patents
1-(6-클로로나프트-2-일설포닐)-4-[4-(4-피리딜)벤조일]피페라진의 입도가 감소된 제형 Download PDFInfo
- Publication number
- KR20010043216A KR20010043216A KR1020007012149A KR20007012149A KR20010043216A KR 20010043216 A KR20010043216 A KR 20010043216A KR 1020007012149 A KR1020007012149 A KR 1020007012149A KR 20007012149 A KR20007012149 A KR 20007012149A KR 20010043216 A KR20010043216 A KR 20010043216A
- Authority
- KR
- South Korea
- Prior art keywords
- chloronaphth
- pyridyl
- benzoyl
- piperazine
- ylsulfonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
GB9809350.3 | 1998-05-02 | ||
PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20010043216A true KR20010043216A (ko) | 2001-05-25 |
Family
ID=10831311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020007012149A KR20010043216A (ko) | 1998-05-02 | 1999-04-27 | 1-(6-클로로나프트-2-일설포닐)-4-[4-(4-피리딜)벤조일]피페라진의 입도가 감소된 제형 |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1084118A1 (sk) |
JP (1) | JP2002513789A (sk) |
KR (1) | KR20010043216A (sk) |
CN (1) | CN1308629A (sk) |
AU (1) | AU3719699A (sk) |
BR (1) | BR9910176A (sk) |
CA (1) | CA2331041A1 (sk) |
EE (1) | EE200000638A (sk) |
GB (1) | GB9809350D0 (sk) |
HU (1) | HUP0102394A3 (sk) |
IL (1) | IL139405A0 (sk) |
NO (1) | NO20005498L (sk) |
PL (1) | PL343705A1 (sk) |
SK (1) | SK16522000A3 (sk) |
WO (1) | WO1999057112A1 (sk) |
ZA (1) | ZA200006036B (sk) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1031563B1 (en) | 1997-09-30 | 2005-12-28 | Daiichi Pharmaceutical Co., Ltd. | Sulfonyl derivatives |
TWI288745B (en) | 2000-04-05 | 2007-10-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
PT1569912E (pt) | 2002-12-03 | 2015-09-15 | Pharmacyclics Llc | Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
DE69835430T2 (de) * | 1997-05-30 | 2007-03-08 | Takeda Pharmaceutical Co. Ltd. | Sulfonamidderivate, ihre herstellung und verwendung |
EP1031563B1 (en) * | 1997-09-30 | 2005-12-28 | Daiichi Pharmaceutical Co., Ltd. | Sulfonyl derivatives |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/hu unknown
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/ja active Pending
- 1999-04-27 EE EEP200000638A patent/EE200000638A/xx unknown
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/pt not_active IP Right Cessation
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/ko not_active Application Discontinuation
- 1999-04-27 CN CN99808217A patent/CN1308629A/zh active Pending
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/sk unknown
- 1999-04-27 PL PL99343705A patent/PL343705A1/xx not_active Application Discontinuation
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 IL IL13940599A patent/IL139405A0/xx unknown
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2331041A1 (en) | 1999-11-11 |
JP2002513789A (ja) | 2002-05-14 |
WO1999057112A1 (en) | 1999-11-11 |
AU3719699A (en) | 1999-11-23 |
ZA200006036B (en) | 2002-01-25 |
BR9910176A (pt) | 2001-01-09 |
NO20005498D0 (no) | 2000-11-01 |
IL139405A0 (en) | 2001-11-25 |
NO20005498L (no) | 2000-11-01 |
PL343705A1 (en) | 2001-08-27 |
HUP0102394A3 (en) | 2003-01-28 |
GB9809350D0 (en) | 1998-07-01 |
HUP0102394A2 (hu) | 2001-12-28 |
SK16522000A3 (sk) | 2001-05-10 |
EP1084118A1 (en) | 2001-03-21 |
EE200000638A (et) | 2002-04-15 |
CN1308629A (zh) | 2001-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2552786C (en) | Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist | |
CN103119030A (zh) | 基质金属蛋白酶抑制剂 | |
CZ293126B6 (cs) | Léčivo k léčení schizofrenie, deprese, neuróz a psychóz | |
JP2015232046A (ja) | 第Xa因子阻害剤の結晶形態 | |
JPH0687856A (ja) | 8‐クロロ‐11‐〔1‐〔(5‐メチル‐3‐ピリジル)メチル〕‐4‐ピペリジリデン〕‐6,11‐ジヒドロ‐5H‐ベンゾ〔5,6〕シクロヘプタ〔1,2‐b〕ピリジン | |
PL207651B1 (pl) | Pochodne diazepanu lub ich sole i zawierające je kompozycja farmaceutyczna oraz inhibitor aktywowanego czynnika krzepnięcia krwi X | |
EA015376B1 (ru) | СОЛИ ПРОИЗВОДНЫХ 6-ГЕТЕРОАРИЛ-(1,2,3,4,4a,10b)-ГЕКСАГИДРОФЕНАНТРИДИНА И ИХ ПРИМЕНЕНИЕ | |
TW200402416A (en) | Novel piperidine derivatives | |
EP2138482A1 (en) | Bicyclic heterocyclic compound | |
AU687128B2 (en) | Prodrugs of an inhibitor of HIV protease | |
JP4230453B2 (ja) | 1−メチル−2−(4−アミジノフェニルアミノメチル)−ベンズイミダゾール−5−イル−カルボン酸−(n−2−ピリジル−n−2−ヒドロキシカルボニルエチル)−アミドの新規プロドラッグ、それらの製造及び医薬組成物としてのそれらの使用 | |
KR20220152293A (ko) | Covid-19 관련 병태의 치료 방법 | |
EP0228959B1 (en) | Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same | |
KR20040015087A (ko) | 만성 관절 류마티즘 치료제 | |
JP4248245B2 (ja) | 6−フェニルベンゾナフチリジン | |
WO2000048996A2 (de) | Beta-alaninderivate | |
KR19980703601A (ko) | 당단백질 IIb/IIIa 길항제 | |
KR20010043216A (ko) | 1-(6-클로로나프트-2-일설포닐)-4-[4-(4-피리딜)벤조일]피페라진의 입도가 감소된 제형 | |
JPS63225355A (ja) | 1,4−ジヒドロピリジン誘導体 | |
WO1998054142A1 (en) | Cyanoguanidines as cell proliferation inhibitors | |
JP2008543770A (ja) | (5z)−5−(6−キノキサリニルメチリデン)−2−[(2,6−ジクロロフェニル)アミノ]−1,3−チアゾール−4(5h)−オン | |
WO2001017990A1 (en) | Heterocyclic derivatives as inhibitors of factor xa | |
CZ20004037A3 (cs) | Forma l-(6-chlornaft-2-ylsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazinu se zmenšenu velikostí částic a farmaceutická kompozice tuto formu obsahující | |
MXPA00010676A (en) | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl]piperazine | |
CN113105391B (zh) | 一种具有镇痛活性的高乌甲素衍生物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |